Clinical Trial: Trial Comparing miLOOP Device Assisted Phacoemulsification vs Standard Surgery for Dense Cataracts: Effects on Endothelial Cell Loss, Energy Use, and Vision Recovery

U.S., Oct. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07898007) titled 'Trial Comparing miLOOP Device Assisted Phacoemulsification vs Standard Surgery for Dense Cataracts: Effects on Endothelial Cell Loss, Energy Use, and Vision Recovery' on Oct. 20.

Brief Summary: The goal of this clinical trial is to find out if using the miLOOP device during cataract surgery confers additional protection against cornea (endothelial) cells loss by reducing the amount of ultrasound energy needed. It will also look at how well patients see after surgery and how safe the procedure is.

The main questions it aims to answer are:

* Does the miLOOP device reduce the loss of corneal endothelial cells during and after catarac...